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DOPC/DOPEinin (BK), Arg1-Pro2-Pro3-Gly4-Phe5-Ser6-Pro7-Phe8-Arg9, was investigated by
Nuclear Magnetic Resonance (NMR) spectroscopy and Monte Carlo simulation in two different media, i.e. in
pure aqueous solution and in the presence of phospholipid vesicles. Monolamellar liposomes are a good
model for biological membranes and mimic the environment experienced by bradykinin when interacting
with G-protein coupled receptors (GPCRs). The NMR spectra showed that lipid bilayers induced a secondary
structure in the otherwise inherently ﬂexible peptide. The results of ensemble calculations revealed
conformational changes occurring rapidly on the NMR time scale and allowed for the identiﬁcation of
different families of conformations that were averaged to reproduce the NMR observables. These structural
results supported the hypothesis of the central role played by the peptide C-terminal domain in biological
environments, and provided an explanation for the different biological behaviours observed for bradykinin.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionBradykinin (BK; Arg1-Pro2-Pro3-Gly4-Phe5-Ser6-Pro7-Phe8-
Arg9) is a nonapeptide hormone produced by enzymatic cleavage of
its high molecular weight precursor, kininogen, at the occurrence of
tissue injury or trauma [1,2]. It is one of the most potent vasodilators
and increases vascular permeability [3]. BK also elicits contraction of
smoothmuscles of the respiratory and gastrointestinal tract and of the
uterus [4], it is active in the central nervous system, where it initiates
pain stimuli and is responsible for the cardinal symptoms of
inﬂammation [5–7].
The conformational analysis of this oligopeptide has been the
object of considerable interest, with the aim of gaining insights into
possible bioactive conformations and developing a structure–activity
relationship [8,9]. The general conclusion of conformational studies in
aqueous solution is that BK exists in random-coil conformational
states [10,11]. BK undergoes conformational modiﬁcations and
assumes a possible bioactive tertiary structure, when complexed to
its receptor [12–14], in the presence of short chain lipids [15], or when
interacting with micellar systems [16–20]. The receptor of BK belongs
to the family of G-protein-coupled receptors, characterized by seven
transmembrane hydrophobic helical segments [21]. A membrane-
bound pathway for the interaction between peptide hormones and
their receptors has been proposed [22]. This implies accumulation and
orientation of the peptide on the membrane surface, which increases
the local concentration of BK and at the same time reduces the degrees39 0577 234177.
ll rights reserved.of its rotational and translational freedom. Such mechanism may also
facilitate the transition from the random coil structure, usually
adopted by peptides in the extracellular environment, to the bioactive
conformation [23].
Unilamellar liposomes are good mimetics of cell membranes, since
bilayers are the basic assembly shared by these systems [24,25].
Indeed, monolamellar liposomes present more realistic features than
other amphiphilic aggregates.
The main purpose of the present study was to investigate the
conformational modiﬁcations induced by membrane-like systems
(dioleoylphospholipid vesicles) on bradykinin molecules by combin-
ing high resolution NMR and computational techniques [26–28]. This
represents a suitable approach to determine the structure of
biologically relevant molecules in different media [29–32]. Previous
studies by electron spin resonance [33] and time-resolved ﬂuores-
cence [34] spectroscopies of labels intercalated in lipid bilayers have
shown that BK and some of its fragments interact with anionic vesicles
of dimyristoylphosphatidylglycerol, with signiﬁcant modiﬁcation of
the bilayer ﬂuidity.
In this work, vesicles were formed with 1,2-dioleoyl-sn-glycero-
phosphocholine (DOPC), and 1,2-dioleoyl-sn-glycerophospho-
ethanolamine (DOPE), which are commonly used to model plasma
membranes, since they give a ﬂuid bilayer at room temperature and
since phosphocholine and phosphoethanolamine are the most
abundant polar head types found in the outer cell membrane [35]. A
comparison was also made with liposomes whose bilayer contained a
negatively charged lipid (1,2-dioleoyl-sn-glycero-3-phosphate mono-
sodium salt, DOPA), in order to reproduce the surface of different cell
types.
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and Zeta Potential, to monitor possible changes in the structure and
surface charge after association with BK molecules.
The obtained results suggested that the biological activity of
bradykinin could be correlated with its interaction with phospholipid
bilayers, and supported the hypothesis of an active role of the
membrane as a promoter of ligand–receptor interaction.
2. Materials and methods
1,2-dioleoyl-sn-glycero-3-phosphocholine, DOPC (purityN99%),
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE (purityN99%)
and 1,2-Dioleoyl-sn-Glycero-3-Phosphate, DOPAwere purchased from
Avanti Polar Lipids, Inc., Alabaster, AL, and used without further
puriﬁcation. All liposomes were prepared with a total lipid concen-
tration of 1×10−2 M in H2O or D2O. The structure and numbering of
DOPC and DOPE lipids are shown in Fig. 1.
Bradykinin, Arg1-Pro2-Pro3-Gly4-Phe5-Ser6-Pro7-Phe8-Arg9,
(purity≥98%) was obtained from Sigma Aldrich, Milano Italy, and
used without further puriﬁcation.
2.1. Sample preparation and characterization
Three different liposomes were used in this work: DOPC/DOPE
(1:1), DOPE/DOPA (1:1) and DOPC/DOPA/DOPE (0.25:0.75:1).
Unilamellar monodisperse lipid vesicles were prepared in the
following manner. Appropriate amounts of DOPC and DOPE stock
solution (4×10−2 M in CHCl3) and of bradykinin stock solution
(1×10−2 M in C2H5OH) were mixed, dried with a nitrogen stream and
kept under vacuumovernight at 303 °K, to remove traces of the organic
solvent. The dried ﬁlms were then dissolved in D2O.
Upon vortexing, multilamellar vesicles were ﬁrst obtained. Sub-
sequent treatment with nine freeze/thaw cycles and 27 extrusion
passages through polycarbonate ﬁlters with 100 nm pore diameter
(Mini-Extruder device, Avestin Inc., Canada) allowed obtaining
unilamellar vesicles of restricted size distribution.
The size of plain- and BK associated-liposomes was determined by
photon correlation spectroscopy (PCS) with a Coulter Sub-Micron
Particle Analyzer Model N4SD (Coulter Corporation, Miami, FL, USA).
Laser light of 632.8 nm wavelength, scattered by the sample at 90°,
was ampliﬁed and then analyzed to obtain a correlation function.
Unimodal ﬁtting, that assumes a log Gaussian distribution of size and
SDP (Size Distribution Processor) ﬁtting, based on the algorithm
CONTIN, were used to obtainmean diameter and polydispersity index.Fig. 1. Structure and numberζ potential measurements were performed with a Coulter DELSA
440 SX apparatus. Home made hemispherical electrodes covered by a
thin gold layer were used as the measure cell. ζ curves were recorded
at four different scattering angles (8.6°, 17.1°, 25.6° and 34.2°) by using
an electromagnetic ﬁeld of 3 V.
2.2. NMR spectroscopy
NMR spectra of plain and BK loaded liposomes were acquired at
298 °K on a Bruker DRX-600 AVANCE spectrometer (Rheinstetten,
Germany), equipped with an xyz gradient unit, and operating at
600.13 MHz for 1H. Two dimensional NOESY spectra (spectral width
8 ppm, number of complex points F2=2048, F1=512) were acquired
using mixing times of 200 and 400 ms and FID's were processed
applied exponential multiple function. Water suppression for the 2D
spectra was performed using the presaturation sequence.
Data were processed with the NMRpipe [36] software (3.3
version), and 2D spectra were analyzed with the SPARKY soft-
waretocsy, (3.1 version) by T.D. Goddard and D.G. Kneller, University
of California, San Francisco.
Constraint distances were generated with the MARDIGRAS algo-
rithm [28], which uses a complete relaxation matrix approach and
assumes overall isotropic molecular motion. As starting model for
MARDIGRAS calculations, the ﬁnal structures of a preliminary
unrestrained molecular dynamics and subsequent full energy mini-
mization were used.
2.3. Molecular modelling and structure reﬁnement
Molecular dynamics simulations and molecular mechanics calcu-
lations were performed with Macromodel 5.0 program [37,38], on
Silicon Graphics (SGI, Sunnyvale, CA, USA), INDIGO 2 Solid Impact
working under IRIX 6.3 operating system. The force ﬁeld used
was AMBER [39]. Total energy was minimized by block diagonal
and full matrix Newton–Raphson minimization without any initial
constraints.
The conformational search analysis was performedwith theMonte
Carlo protocol [40] and the global minimum structure was selected
from populated low energy conformers. Experimentally-derived
structural constraints were introduced in the calculations. All
minimizations were performed by gradient convergence and were
continued until the RMS derivative was below 0.01 kJ/Å. A structural
test based on the eigenvalues of the second derivative matrix was
performed in order to evaluate the presence of local saddle points.ing of DOPC and DOPE.
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after molecular dynamics calculations was evaluated on the basis of
the XCluster method [41].
3. Results and discussion
Fig. 2 shows the proton spectra recorded at 600MHz and 298 K for:
a) BK (1.4.10−2 M) in D2O solution; b) DOPC/DOPE (1:1) liposome; c)Fig. 2. NMR proton spectra recorded at 600 MHz and 298 K for: (a) BK (1.4×10−2DOPC/DOPE:BK (5:1). Proton signal assignment was based on COSY,
TOCSY and NOESY spectra and was in agreement with literature data
[42–45] (COSYand TOCSY spectra not shown). In particular, the signals
at 7.19 ppm and 7.29 ppm were assigned to aromatic protons (H2,6
and H3,5) for the amino acid Phe5. For the Phe8 the aromatic protons
gave resonances at 7.24 ppm (H2,6) and 7.33 ppm (H3,5). The signals
at 4.32 ppm and 4.10 ppmwere due to theα protons of Arg1 and Arg9,
respectively.M) in D2O solution; (b) DOPC/DOPE (1:1) liposome; (c) DOPC/DOPE:BK (5:1).
Table 1
Proton assignments of DOPC/DOPE liposomes
Hn Chemical shift (ppm)
H1 0.80
H2 1.20
H3β 1.60
H5α 2.30
H4 1.95
H6 3.20
H7 3.65
H9′ 4.25
H11 4.30
H8 4.40
H10, H12 5.30
Table 2
Inter-residue proton dipolar cross-peaks for BK in D2O solution obtained by NOESY
spectrum
Residue 1 Atom 1 Residue 2 Atom 2
Pro2 Hδ1 Arg1 Hα
Pro2 Hδ2 Arg1 Hα
Pro3 Hδ1 Pro2 Hα
Pro3 Hδ2 Pro2 Hα
Gly4 Hα1 Ser6 Hα
Ser6 Hα Pro7 Hα
Pro7 Hδ Ser6 Hα
Pro7 Hβ1 Phe8 H(2,6)
Pro7 Hβ1 Phe8 H(3,5)
711C. Bonechi et al. / Biochimica et Biophysica Acta 1788 (2009) 708–716The 1H spectrum of DOPC/DOPE liposomes in D2O solution (Fig. 2B)
showed broad and unresolved signals, which did not allow the
determination of proton–proton scalar couplings. As commonly found
in this kind of systems, the poor resolution of resonances was a typical
characteristic of amphiphilic molecules that form aggregates. It was
due both to slow molecular motions and to incompletely averaged
dipolar interactions inside the aggregate. In general, NMR studies ofFig. 3. NOESY spectrum of BK in D2O solution recorded at 600 MHz, with mixing time of 400
amino acids has been reported. In this ﬁgure the blue colors refer to the Arg1 and Arg9 cropeptides incorporated into membranes are extremely difﬁcult, due to
drastic line broadening, high concentration of protons in the lipids
compared to the embedded peptide, and signal overlap. In our case,
however, the choice of monodisperse liposomes with diameters in the
range 120–140 nm allowed obtaining of NMR spectra with fairly
narrow and well resolved resonances, thus overcoming the main
drawbacks of this otherwise powerful method.ms. In the insertion the expanded region of α and β, γ, δ protons in the Arg1 and Arg9
ss-peaks which are in the fast motion condition.
Table 3
Intensity of inter-residue cross-peaks for BK in D2O solution from NOESY spectrum
Residue 1 Atom 1 Residue 2 Atom 2 Intensity Distance (Å)±0.1
Pro2 Hδ Arg1 Hα Strong 2.5
Pro2 Hδ2,1 Arg1 Hα Strong 2.3
Pro3 Hδ1 Pro2 Hα Strong 2.2
Pro3 Hδ2 Pro2 Hα Strong 2.3
Pro7 Hα Ser6 Hα Medium 3.3
Gly4 Hα2 Ser6 Hα Weak 5.0
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reported in Table 1. Fig. 2C shows the 1H spectrum of DOPC/DOPE
liposomes containing BK at 1:5 molar ratio with respect to lipids. The
NMR resonances of the peptide, in the presence of DOPC/DOPE
liposomes, were slightly downﬁeld shifted (−0.034 to −0.040 ppm)
with respect to those of BK in aqueous solution. The similarity
between the two spectra was attributed to BK exchange between a
free state in solution and a membrane-bound state, which caused line
broadening of the spectrum without substantially changing the
chemical shifts. In the spectrum of Fig. 2C some resonances of BK
were still clearly evident, and allowed to study the interaction sites of
BK in liposome containing systems. The supposed interaction between
BK and liposomes was investigated by NOESY spectra, with the aim of
pointing out the differences in the dipolar interactions that occur in
aqueous solution and in the presence of liposomes. NOESY experi-
ments are the most useful tool to identify spatial connectivities
between nuclei which interact through dipole–dipole couplings, since
the size of the NOE is inversely dependent on the distance between
interacting spins. The NOESY spectrum of BK in D2O solution (Fig. 3)
showed no indication of an existing secondary structure, since the
pattern of NOEs did not reveal any additional signiﬁcant connectiv-
ities. For BK in D2O solution it was also evident that the cross-peak
between Arg1 and Arg9, N-terminal and C-terminal amino acids
respectively, showed opposite sign with respect to diagonal peaks
(insert of Fig. 3). The relative sign of cross-peaks in a NOESY spectrum
depends on the rotational correlation time, i.e. if the rotational
correlation time of the molecules is short, the diagonal and cross-
peaks have opposite signs [46]. This result allowed assertion that the
terminal amino acids of BK experienced a faster motion with respect
to backbone amino acids. Both amino acids (Arg1 and Arg9) showed
this behaviour in D2O solution. Only the observed inter residue dipolar
cross-peaks in the NOESY spectrum of BK are reported in Table 2. TheFig. 4. Three families of conformation for BK having the best agreemenNOESY spectrum in water displayed very few inter-residue cross-
peaks, mainly the αHi and δCH2(i+1). Cross-peaks between Arg1 αH-
Pro2 δCH2 and Pro2 αHPro3 δCH2 suggested a trans conformation for
the two proline residues. In fact, the cis form would induce much
closer contacts between αHi and αH(i+1), whereas the trans form
promotes short distances between αHi and δCH2(i+1) [47]. It may be
noted that native BK was also found in a trans arrangement of proline
residue in water [47].
Lack of NMR experimental data attributable to secondary struc-
ture, made it difﬁcult to deﬁne the structural motif of a preferential
conformation.
Geometrical restraints were derived from the cross-peak volumes
of NOESY spectrum, classifying semi-quantitatively distances into
three categories: weak (d=3.7–5.0 Å), medium (d=2.5–3.7 Å) and
strong (d=1.8–2.5 Å) [47].
These data were used for theoretical simulations of molecular
mechanics and/or molecular dynamics. Here, the procedure involved
the following steps: (i) calculation of 1H–1H distances from NOESY
intensities by complete relaxation matrix analysis using MARDIGRAS
program; (ii) application of restrained molecular mechanics, using a
Monte Carlo (MC) [48] approach for sampling the conformational
space or molecular dynamic simulations; (iii) statistical analysis of the
pool of conformers obtained by the MC simulation, using the program
XCluster [49]; (iv) comparison of the free bradykinin conformation
and conformational modiﬁcation in the presence of DOPC/DOPE
vesicles.
The NOESY peak volumes were obtained with the Sparky software
and used as input values in the MARDIGRAS program. The calculated
inter-residue network for BK is reported in Table 3. These proton–
proton distances were used as restraints in the Monte Carlo (MC)
simulation. Monte Carlo simulations have been demonstrated to be an
important tool in the investigation of peptide-membrane interactions
[50,51]. We followed a standard MC protocol to sample the
conformational space of the peptide in the aqueous phase, using the
inter-residue restraints reported in Table 3, and the intra-residue
correlation. The acceptance of each step, which creates a new
conformation from the previous one, was based on the Metropolis
criterion [51] and the internal energy difference between the new and
the old state. In theMC protocol, a total of 159 structures of low energy
were calculated with an energy global minimum of −1042 kJ/mol and
other local energy minima in the range of 4.18, 8.37, 12.55, 20.92, and
41.84 kJ/mol with respect to the absolute minimum.t with the NOESY distance constraints after the clusters procedure.
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relative violations of the distance restraint above 1.2–1.5 Å. Thus, we
obtained 60 families of conformations. These conformational families
represented a structure of bradykinin in aqueous solution only if taken
as a whole. In order to calculate the probability of existence of the
obtained conformational families, the number of constraints which
were respected, was checked. This ensemble of conformations
includes all possible secondary structures for the C-terminus of
bradykinin. In particular, the ﬁrst group of families was the oneFig. 5. NMR proton spectra recorded at 600 MHz and 298 K for: (a) DOPC/Dobserved from the type I β-turn. A second group of structure clustered
around dihedral angle values of a distorted type II β-turn. A third
family was intermediate between the two previous ones, and
produced a structure that was partially extended instead of being
bent. The turn region of representative structures, taken from the
three families of conformations obtained from the ensemble calcula-
tions, is shown in Fig. 4. This experimental evidence resembled the
behaviour of peptides in the presence of receptors. Indeed, bradykinin
adopts an active form in solution, when interacting with its receptor.OPE:BK (5:1); (b) DOPE/DOPA:BK (5:1); (c) DOPC/DOPA/DOPE:BK (5:1).
Table 4
Size and surface charge of liposomes in pure water and in the presence of BK (1:5 molar
ratio with respect to total lipids=1×10−2 M)
Sample composition Mean diameter
(D, nm)
Polyd. index D95% (nm) of
size distribution
ξ (mV)
DOPC/DOPE (1/1) 125 0.15 122–129 −20±5
DOPC/DOPE (1/1)+BK 140 0.14 139–144 +4±5
DOPC/DOPA/DOPE
(0.25/0.75/1)
133 0.12 130–135 −29±2
DOPC/DOPA/DOPE
(0.25/0.75/1)+BK
128 0.09 125–130 −10±5
DOPA/DOPE (1/1) 129 0.17 125–133 −37±2
DOPA/DOPE (1/1)+BK 120 0.11 117–123 0±2
In the forth column the width of the diameter distribution is reported for the 95% of
total aggregate population.
Table 5
Intensity of cross-peaks for DOPC/DOPE:BK (5:1) from NOESY spectrum
Residue 1 Atom 1 Residue 2 Atom 2 Intensity Distance (Å)±0.1
Pro3 Hδ2 Pro2 Hα Strong 2.4
Phe5 Hβ Phe5 H(2,6) Strong 2.5
Phe8 Hα Phe8 H(3,5) Medium 3.0
Phe8 H(2,6) Pro7 Hβ1 Weak 4.0
Phe8 H(3,5) Pro7 Hβ1 Weak 4.1
Phe5 Hβ Phe5 H(3,5) Weak 4.3
Phe8 Hβ1 Phe8 H(3,5) Weak 4.6
Phe8 Hβ2 Phe8 H(3,5) Weak 4.6
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bound activation pathway. This has also been proposed for a number
of peptides and receptors [52–55].
As mentioned above, mono and bidimensional NMR experiments
were also performed for liposomes containing the negative lipid
DOPA, which is a constituent of many bacterial membranes. Bilayers
made up with DOPE and DOPA at 1/1 molar ratio and with DOPC,
DOPA and DOPE at 0.75/0.25/1 molar ratio were investigated, either in
the form of BK free systems or in the presence of bradykinin 5:1 mol:
mol with respect to total lipids. The corresponding proton NMRFig. 6. Two-dimensional NOESY strips, in two different regions, from 600 MHz anspectra are reported in Fig. 5. By comparing Fig. 5A–C, it could be
observed that only the system DOPC/DOPE:BK gave a spectrum in
which BK proton resonances were observable. In the two other
systems, BK signals disappeared, in particular those of the phenyla-
lanine aromatic protons (7–8 ppm). These evidences suggested that in
DOPE/DOPA:BK and DOPC/DOPA/DOPE:BK systems, the peptide
completely adhered on the liposome surface, preventing the observa-
tion of BK NMR signals. Indeed, the DOPE/DOPA and DOPC/DOPA/
DOPE liposomes have a strongly negative surface charge (−37 mV±2
and −29mV±2 respectively), which is in agreementwith the observed
strong interaction. A similar behaviour is reported by Marcotte et al.
[55] for a pentapetide of the enkephalin family, whose interaction
with model membrane (PC and PG bicelles) depends on the nature ofd 400 ms mixing time for: (a) DOPC/DOPE:BK (5:1); (b) BK in D2O solution.
Fig. 7. Only two conformational families for BK in DOPC/DOPE vesicles, obtained by XCluster procedure.
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surface charge of plain and BK interacting liposomes for the three
different bilayer types studied in this work. Data indicated that
vesicles diameter did not change substantially after bradykinin
addition. The low polydispersity indexes measured for all the systems
showed that liposomes were not deeply altered upon interactionwith
this peptide and remained fairly monodisperse. These features were
found to be reproducible and did not change at different liposome
concentrations (dilution of the whole systemwas performed up to 20
times the starting value of 1×10−2 M total lipids).
In order to study the conformational modiﬁcation of BK in the
DOPC/DOPE:BK (5:1) system more in detail, the NOESY spectrum of
the peptide plus vesicles systemwas analyzed (Fig. 6A) and compared
to the NOESY spectrum of BK without vesicles (Fig. 6B). The NOESY
spectrum of DOPC/DOPE:BK (5:1) system displayed some correlations,
indicating the adoption of a BK preferred conformation upon
interaction with DOPC/DOPE vesicles. The cross-peaks were also
broadened with respect to those of BK without lipids, indicating that
the peptide underwent slower tumbling as a result of the binding
process.
The comparison of NOESY spectra is also important to underline
the difference between DOPC/DOPE:BK (5:1) and BK in D2O solution.
The ﬁrst important evidence concerned the sign of amino acids Arg1
and Arg9 cross-peaks. Contrarily to the results for BK without vesicles,
the cross-peaks of Arg1 and Arg9 Hα and Hδ showed the same sign of
diagonal peaks for the DOPC/DOPE:BK (5:1) (Fig. 6(a1)). This
suggested the existence of a slow motion regime for the two amino
acids.We thus concluded that the terminal amino acids did not showa
different motional regime with respect to the backbone, and that BK
molecules were associated with slowly tumbling large aggregates.
The dipolar cross-peaks for the DOPC/DOPE:BK system are
reported in Table 5. Noteworthy: (i) some inter-residue cross-peaks
observed in the liposome free systems were no longer present and (ii)
the dipolar interactions between aromatic protons of Phe5 and Phe8
appeared (Fig. 6(a2)). These experimental data conﬁrmed that the
peptidemolecule strongly interactedwith liposomes, which induced a
preferential secondary structure. In particular, in the NOESY spectrum
of the DOPC/DOPE:BK system (Fig. 6(a1)), the cross-peaks Arg1 Hγ–
Hδ (1.65–3.08 ppm) and Arg1 Hβ –Hδ (1.65–3.08 ppm) were absent,
while the same cross-peaks for the Arg9 were present. Therefore, we
concluded that in the DOPC/DOPE:BK system the Arg1 residue was
directly involved in the interaction with the surface of liposomes.
The intensities of these cross-peaks were converted into distances
using the MARDIGRAS software and the obtained structural informa-
tion was used as constraints in the Monte Carlo procedure. The MC
protocol allowed obtaining of a total of 108 low energy structures,
with an energy global minimum of −1086 kJ/mol. As reported above,the XCluster analysis allowed deﬁnition of 9 families of structures,
where the experimental restraints were fully respected. Indeed, this
amino acid showed an optimal conformation to interact with surface
of liposome, whereas the Arg1 was not involved in intramolecular
interactions. As reported in Fig. 7, two clusters show a predominant
conformation for the N-terminal amino acid.
The interaction between DOPC/DOPE phospholipids and bradyki-
nin is driven by the phosphate groups, oriented toward the liposome
outer surface (as suggested by the negative ζ potential values of BK
free liposomes), which is able to induce the rearrangement of the Arg1
residue.
4. Conclusions
Small peptides, like bradykinin, do not have a single stable
conformation in solution. The conformation responsible for their
biological behaviour is adopted only at the active site, and also in this
case the ﬂexibility of the biomolecule determines the mechanism of
action. In this study, we showed that BK molecules interact with
zwitterionic lamellar systems and that the amino acid Arg1 is directly
involved in this process, possibly in tight contact with the polar head
groups. Therefore, Arg1 acts as a tethering point between the peptide
and the membrane surface. The central portion of the amino acid
sequence (Pro2-Pro3-Gly4-Phe5), may contribute to anchor the
peptide to the membrane environment and to maintain the N- and
C-termini amino acids in the optimal topological orientation. Overall,
the interaction with the membrane surface provided the topological
arrangement of the biologically important ligand regions. Moreover, it
was found that the aromatic amino acids (Phe5 and Phe8) also showed
a preferential conformation in the presence of liposome.
In conclusion, this study supports the idea that membranes play a
crucial role in inducing and stabilizing the structures of peptide
hormones.
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